Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Federico Hawkins Carranza has a total of 67 co-authors. Here are the top co-authors by number of shared publications:

  • Cristina Martín-Arriscado Arroba

    Scientific Support Unit, Research Institute (imas12), University Hospital 12 de Octubre, Madrid, Spain

    5 shared publications
  • Guillermo Martínez Díaz-Guerra

    Instituto de Investigacion Sanitaria Imas12, Hospital Universitario 12 de Octubre, Universidad Complutense, Madrid

    5 shared publications
  • Sonsoles Guadalix Iglesias

    Thyroid Cancer Unit, Service of Endocrinology, University Hospital 12 de Octubre, Madrid, Spain

    4 shared publications
  • Arturo Corbatón-Anchuelo

    Diabetes Research Laboratory, Biomedical Research Foundation. University Clinical Hospital San Carlos, Faculty of Medicine, Complutense University, 28040 Madrid, Spain

    2 shared publications
  • Eduardo Ferrero Herrero

    Department of Surgery, University Hospital 12 de Octubre, Faculty of Surgery, University Complutense, Madrid, Spain

    2 shared publications
  • Félix Bermejo Pareja

    Research Institute i+12, University Hospital 12 de Octubre, Department of Medicine, Faculty of Medicine, Complutense University, 28040 Madrid, Spain

    2 shared publications

Latest Publications

  • Open Access

    Age-related Reference Data for Cortical and Trabecular 3D-DXA Parameters: the SEIOMM-3D-DXA Project

    by Enrique Casado, Silvana Di Gregorio, Carmen Valero, Jesus Gonzalez-Macias, Jose Manuel Olmos, Rosa Maria Arboiro-Pinel, Manuel Diaz-Curiel, Maria Angeles Vazquez-Gamez, Maria Giner, Maria Jose Montoya-Garcia, et al.

    Purpose: Osteoporosis and associated hip fractures are a major public health concern. Dualenergy X-ray Absorptiometry (DXA) remains the diagnostic gold standard, but its areal (a) bone mineral density (BMD) measurements have limited sensitivity, as many fractures occur at T-scores above −2.5. Three-dimensional (3D) DXA provides compartment-specific volumetric parameters of the hip, potentially improving osteoporosis management. This study aimed to establish reference data for 3D-DXA parameters to improve osteoporosis management and investigate potential compartmental imbalances at the hip. Method: This multicenter, cross-sectional, population-based observational study (SEIOMM-3D-DXA project), supported by the Spanish Society for Bone and Mineral Metabolism (SEIOMM), analyzed hip DXA scans from 1366 Spanish men and women across six centers. 3D-DXA analyses were conducted using the 3D-Shaper software (3D-Shaper Medical, Barcelona, Spain), producing estimates of trabecular volumetric (v) BMD and cortical surface (s) BMD. Age- and sex-specific reference curves were generated using the LMS method, and thresholds were established based on regression with T-score values. Moreover, trabecular vBMD and cortical sBMD Z-scores were calculated to evaluate potential compartmental imbalances. Results: The derived aBMD curves closely aligned with the NHANES III Caucasian reference. Sex-specific thresholds for trabecular vBMD and cortical sBMD were established for patient stratification. Z-score comparisons revealed significant discrepancies between trabecular and cortical compartments in 52.0% of females and 48.7% of males, underlining the importance of compartment-specific bone assessment. Conclusions: This study establishes reference curves for clinical interpretation of 3D-DXA parameters and demonstrates the potential of 3D-DXA to capture compartmental imbalances at the hip. Mini In this study, hip scans from over a thousand men and women in Spain were analyzed to create normative reference values for 3D-DXA parameters. These results can help doctors better stratify people based on the status of each part of the bone and improve the management of osteoporosis.


  • Hip fractures and type 2 diabetes in the elderly: Risk factors analysis of the Nedices cohort

    by Federico Hawkins Carranza, Cristina Martín-Arriscado Arroba, Arturo Corbatón-Anchuelo, Guillermo Martínez Díaz-Guerra, Félix Bermejo Pareja


  • Health-Related Quality of Life Long-Term Study in Lung Transplant Patients: A Single-Center Experience

    by Lourdes Juarros Monteagudo, Guillermo Martinez Diaz-Guerra, Antonio Álvarez Badillo, Carlos J. Álvarez Martínez, Alicia De Pablo Gafas, Antonio P. Gámez García, Eloisa López López, Cristina Martin Arriscado, Federico Hawkins Carranza


  • Open Access

    Comparison of Bone Mineral Density and Trabecular Bone Score in Patients with and without Vertebral Fractures and Differentiated Thyroid Cancer with Long-Term Serum Thyrotrophin-Suppressed Therapy

    by Federico Hawkins Carranza, Cristina Martin-Arriscado Arroba, María Begoña López Alvarez, Soledad Librizzi, Guillermo Martínez Díaz Guerra

    Introduction: The study of BMD provides only partial information on bone health in patients undergoing TSH suppression therapy due to differentiated thyroid cancer (DTC). The trabecular bone score (TBS), a new parameter assessing bone microarchitecture, is proposed for studying bone in this context. This study aimed to analyze their long-term use in patients with DTC. Methods: Bone mineral density (BMD) was measured by dual X-ray densitometry (DXA) and TBS was assessed with iNsigth software (version 2.0, MediImaps, France) in 145 postmenopausal patients with DTC. Vertebral fractures (VFs) were identified using a semi-quantitative X-ray method. Results: The BMD at the end of this study did not differ from the initial measurement. However, the TBS decreased from 1.35 ± 0.1 to 1.27 ± 0.1 (p = 0.002). Increased levels of PTH, osteocalcin, and bone alkaline phosphatase (BAP) were observed, suggesting enhanced bone remodeling. There was an increase in the prevalence of osteoporosis and osteopenia (40.6% and 16.5% to 46.6% and 18.6%, respectively). The proportion of patients with partially degraded and totally degraded TBS increased from 31% and 15.1% to 48.9% and 24.8% by the end of this study. Among the 30 patients with VFs, there were no significant differences in age, body mass index (BMI), calcium intake, alcohol consumption, smoking, radioiodine, therapy, or thyroid parameters compared to those without VFs. The odds ratio for VFs increased with osteopenia (OR 2.63). Combining TBS with BMD did not improve discrimination. Conclusions: The TBS decreased while the BMD remained unchanged. The percentage of patients with osteoporosis and osteopenia, whether partially degraded or totally degraded, increased by the end of this study. The predominant discordance was found in partially degraded microarchitectures, with a higher proportion of osteopenic patients compared to those with normal or osteoporotic bone density. The AUC of the combination of TBS and BMD did not enhance discrimination. TBS, radioactive iodine therapy, and sedentary lifestyle emerged as the main distinguishing factors for DTC patients with VFs.


  • Open Access

    Comparison of BMD and TBS Scores in Patients with and without Vertebral Fractures and Thyroid Cancer with Long-Term TSH-Suppressed Therapy

    by Federico Hawkins Carranza, Cristina Martin-Arriscado Arroba, Maria Begoña Lopez Alvarez, Soledad Librizzi, Guillermo Martinez Diaz-Guerra

    Introduction: BMD study gives partial information on bone health in patients with TSH suppression therapy due to Differentiated Thyroid Cancer (DTC). TBS, a new parameter of bone microarchitecture is propose for bone quality study. This study analyze their long-term use in patients with DTC. Methods: BMD was measured by DXA and TBS with iNsigth software in 145 postmenopausal DTC patients. Vertebral Fractures (VFs) with a semi-quantitative x-ray method. Results: BMD at the end study was not different from initial. TBS decreased from 1.35±0.1 to 1.27±0.1 (p=0.002). PTH, Osteocalcin, and BAP were increased, suggesting increased bone remodeling. There was an increase in osteoporosis and osteopenia (40.6% and 16.5% to 46.6% and 18.6%); 31% had partially degraded and 15.1% degraded TBS changed to 48,9% and 24,8% at the end study. VFs in 30 patients, was not different in age, BMI, calcium and alcohol ingestion, smoking, radioiodine, or thyroid parameters vs. without VFs. Odds ratio for VFs increased with osteopenia (OR 2.63). Combination of TBS plus TBS did not improve discrimination. Conclusions: TBS was lowered while BMD did not differ. Percentage of osteoporosis and osteopenia and of partially degraded and degraded TBS was higher at the end study. Predominant discordance rate was found in partially degraded microarchitecture, in which the proportion of osteopenia was higher than normal or osteoporotic patients. AUC of TBS plus BMD did not improve discrimination. TBS, radioactive iodine, and sedentary lifestyle were the main differential data for patients with DTC and VFs.

  • Open Access

    Incidence of type 2 diabetes in the elderly in Central Spain: Association with socioeconomic status, educational level, and other risk factors

    by Federico Hawkins Carranza, Arturo Corbatón-Anchuelo, Félix Bermejo Pareja, Cristina Martín-Arriscado Arroba, Saturio Vega-Quiroga, Julián Benito-León, Manuel Serrano-Ríos


  • Open Access

    Association of Low Serum 25OHD Levels with Abnormal Bone Microarchitecture in Well-Differentiated Thyroid Cancer

    by Federico Hawkins Carranza, Sonsoles Guadalix Iglesias, María Luisa De Mingo Dominguez, Gonzalo Allo Miguel, Cristina Martín-Arriscado Arroba, Begoña López Alvares, Guillermo Martínez Diaz-Guerra

    The association of low levels of 25 hydroxyvitamin D (25OHD) with papillary thyroid cancer (PTC) is being studied, as to whether it is a risk factor or as a coincidental one. This study aimed to evaluate serum levels of deficiency, insufficiency, and sufficiency of 25OHD in PTC and its relationship with the trabecular bone score (TBS) and bone mineral density (BMD). This study includes 134 postmenopausal women with PTC, followed for 10 years. BMD was measured with DXA Hologic QDR 4500, and TBS with Med-Imaps iNsight2.0 Software. Mean serum 25OHD was 23.09 ± 7.9 ng/mL and deficiency, insufficiency, and sufficiency levels were 15.64 ± 2.9, 25.27 ± 2.7, and 34.7 ng/mL, respectively. Parathyroid hormone (PTH) and bone alkaline phosphatase (BAP) were higher in deficiency (57.65 ± 22.6 ng/mL; 29.5 ± 14 U/L) and in insufficiency (45.88 ± 19.8 ng/mL; 23.47 ± 8.8 U/L) compared with sufficiency of 25OHD (47.13 ± 16 and 22.14± 9.7 ng/mL) (p = 0.062 and p = 0.0440, respectively). TBS was lower in patients with 25OHD < 20 ng/mL (1.24 ± 0.13) compared with between 20–29 (1.27 ± 0.13, p < 0.05) and 30 ng/mL (1.31 ± 0.11, p < 0.01). We found low TBS in patients with PTC and long-term follow-up associated with low serum 25OHD levels, not associated with cancer stage, or accumulative iodine radioactive dose. Low 25OHD associated with deleterious bone quality in patients with PTC should be restored for the prevention of fractures.


  • Open Access

    Trabecular bone deterioration in differentiated thyroid cancer: Impact of long‐term TSH suppressive therapy

    by Federico Hawkins Carranza, Sonsoles Guadalix Iglesias, María Luisa De Mingo Domínguez, Cristina Martín‐Arriscado Arroba, Begoña López Álvarez, Gonzalo Allo Miguel, Guillermo Martínez Díaz‐Guerra

    Background: Conflicting results has been reported regard osteoporosis and fractures in patients with Differentiated Thyroid Cancer (DTC). Our objective was to evaluate the long‐term effects of TSH suppression therapy with Levothyroxine (LT4) on trabecular bone score (TBS) and bone mineral density (BMD) in females with DTC after thyroidectomy.Methods: About 145 women with resected DTC and receiving long‐term TSH therapy, were stratified according to the degree of TSH suppression. Mean duration of follow‐up was 12.3 ± 6.1 years. BMD and TBS, were assessed using dual‐energy X‐ray absorptiometry (DXA) and TBS iNsight (Med‐Imaps), at baseline (1‐3 months after surgery) and at the final study visit.Results: In patients stratified by duration of TSH suppression therapy (Group I, 5‐10 years; Group II, >10 years), slight increases from baseline TSH levels were observed. Significant decreases in LS‐BMD and FN‐BMD were seen in patients after >10 years. TBS values were lower in Groups I (1.289 ± 0.122) and II (1.259 ± 0.129) compared with baseline values (P = .0001, both groups). Regarding the degree of TSH suppression, TBS was significantly reduced in those with TSH < 0.1 µU/mL (P = .0086), and not in patients with TSH suppression of 0.1.‐0.5 or >0.5 µU/mL.Conclusions: We found deterioration of trabecular structure in patients with DTC and TSH suppression therapy below 0.1 µU/mL and after 5‐10 years of follow‐up. Significant changes in BMD according to TSH levels were not observed. Trabecular Bone Score is a useful technique for identifying thyroid cancer patients with risk of bone deterioration.


  • Postransplantation metabolic bone disease

    by Real Academia Nacional de Medicina de España, Federico Hawkins-Carranza, María Begoña López-Álvarez, María Ángeles Valero-Samuy, Sonsoles Guadalix-Iglesias, María Soledad Librizzi, Guillermo Martínez-Díaz-Guerra

  • Trabecular bone score and bone mineral density in patients with postsurgical hypoparathyroidism after total thyroidectomy for differentiated thyroid carcinoma

    by Sonsoles Guadalix Iglesias, María Luisa De Mingo Dominguez, Eduardo Ferrero Herrero, José Ignacio Martinez-Pueyo, Cristina Martín-Arriscado Arroba, Guillermo Martínez Diaz-Guerra, Federico Hawkins Carranza